364 related articles for article (PubMed ID: 33963482)
1. Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer.
Nelson MA; Ngamcherdtrakul W; Luoh SW; Yantasee W
Cancer Metastasis Rev; 2021 Jun; 40(2):519-536. PubMed ID: 33963482
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic strategies in breast cancer: A clinical update.
Zhang JQ; Plitas G
J Surg Oncol; 2021 Mar; 123(3):710-717. PubMed ID: 33155281
[TBL] [Abstract][Full Text] [Related]
3. Targeting the immune microenvironment for ovarian cancer therapy.
Blanc-Durand F; Clemence Wei Xian L; Tan DSP
Front Immunol; 2023; 14():1328651. PubMed ID: 38164130
[TBL] [Abstract][Full Text] [Related]
4. B cells imprint adoptively transferred CD8
Smith AS; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Rivera-Reyes AM; Dwyer CJ; Ware MB; Cole AC; Neskey DM; Rubinstein MP; Liu B; Thaxton JE; Bartee E; Paulos CM
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017148
[TBL] [Abstract][Full Text] [Related]
5. IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy.
Lee KJ; Choi D; Tae N; Song HW; Kang YW; Lee M; Moon D; Oh Y; Park S; Kim JH; Jeong S; Yang J; Park U; Hong DH; Byun MS; Park SH; Sohn J; Park Y; Im SK; Choi SS; Kim DH; Lee SW
Cell Rep Med; 2024 May; 5(5):101567. PubMed ID: 38744277
[TBL] [Abstract][Full Text] [Related]
6. Adoptive cell immunotherapy for breast cancer: harnessing the power of immune cells.
Li X; Zhu Y; Yi J; Deng Y; Lei B; Ren H
J Leukoc Biol; 2024 Apr; 115(5):866-881. PubMed ID: 37949484
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in Sarcoma: Current Data and Promising Strategies.
Wood GE; Meyer C; Petitprez F; D'Angelo SP
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432234. PubMed ID: 38781557
[TBL] [Abstract][Full Text] [Related]
8. Circadian tumor infiltration and function of CD8
Wang C; Zeng Q; Gül ZM; Wang S; Pick R; Cheng P; Bill R; Wu Y; Naulaerts S; Barnoud C; Hsueh PC; Moller SH; Cenerenti M; Sun M; Su Z; Jemelin S; Petrenko V; Dibner C; Hugues S; Jandus C; Li Z; Michielin O; Ho PC; Garg AD; Simonetta F; Pittet MJ; Scheiermann C
Cell; 2024 May; 187(11):2690-2702.e17. PubMed ID: 38723627
[TBL] [Abstract][Full Text] [Related]
9. Emerging measurements for tumor-infiltrating lymphocytes in breast cancer.
Wu R; Horimoto Y; Oshi M; Benesch MGK; Khoury T; Takabe K; Ishikawa T
Jpn J Clin Oncol; 2024 Jun; 54(6):620-629. PubMed ID: 38521965
[TBL] [Abstract][Full Text] [Related]
10. Biomaterial-based scaffolds for direct in situ programming of tumor-infiltrating T lymphocytes.
Inamdar VV; Hao S; Stephan SB; Stephan MT
J Control Release; 2024 Jun; 370():310-317. PubMed ID: 38677524
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy.
Feist M; Zhu Z; Dai E; Ma C; Liu Z; Giehl E; Ravindranathan R; Kowalsky SJ; Obermajer N; Kammula US; Lee AJH; Lotze MT; Guo ZS; Bartlett DL
Cancer Gene Ther; 2021 Feb; 28(1-2):98-111. PubMed ID: 32632271
[TBL] [Abstract][Full Text] [Related]
12. The role of immune infiltrates as prognostic biomarkers in patients with breast cancer.
Baxevanis CN; Sofopoulos M; Fortis SP; Perez SA
Cancer Immunol Immunother; 2019 Oct; 68(10):1671-1680. PubMed ID: 30905043
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in breast cancer: An introduction.
Disis ML; Stanton SE
Breast; 2018 Feb; 37():196-199. PubMed ID: 28162837
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency radiation reshapes tumor immune microenvironment into antitumor phenotype in pulmonary metastatic melanoma by inducing active transformation of tumor-infiltrating CD8
Jiao JZ; Zhang Y; Zhang WJ; He MD; Meng M; Liu T; Ma QL; Xu Y; Gao P; Chen CH; Zhang L; Pi HF; Deng P; Wu YZ; Zhou Z; Yu ZP; Deng YC; Lu YH
Acta Pharmacol Sin; 2024 Mar; ():. PubMed ID: 38538718
[TBL] [Abstract][Full Text] [Related]
15. The Tumor Immune Microenvironment in Breast Cancer Progression.
Otterlei Fjørtoft M; Huse K; Rye IH
Acta Oncol; 2024 May; 63():359-367. PubMed ID: 38779867
[TBL] [Abstract][Full Text] [Related]
16. Targeting metabolism of breast cancer and its implications in T cell immunotherapy.
Zou J; Mai C; Lin Z; Zhou J; Lai G
Front Immunol; 2024; 15():1381970. PubMed ID: 38680483
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models.
Xue H; Zhang Z; Li L; Zhu C; Fei K; Sha H; Wu Z; Lin X; Wang F; Zhou S; Deng X; Li Y; Chen B; Xiong Y; Chen K
Cancer Immunol Immunother; 2024 Mar; 73(5):81. PubMed ID: 38554184
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.
Chu Y; Dai E; Li Y; Han G; Pei G; Ingram DR; Thakkar K; Qin JJ; Dang M; Le X; Hu C; Deng Q; Sinjab A; Gupta P; Wang R; Hao D; Peng F; Yan X; Liu Y; Song S; Zhang S; Heymach JV; Reuben A; Elamin YY; Pizzi MP; Lu Y; Lazcano R; Hu J; Li M; Curran M; Futreal A; Maitra A; Jazaeri AA; Ajani JA; Swanton C; Cheng XD; Abbas HA; Gillison M; Bhat K; Lazar AJ; Green M; Litchfield K; Kadara H; Yee C; Wang L
Nat Med; 2023 Jun; 29(6):1550-1562. PubMed ID: 37248301
[TBL] [Abstract][Full Text] [Related]
19. CD8
Giles JR; Globig AM; Kaech SM; Wherry EJ
Immunity; 2023 Oct; 56(10):2231-2253. PubMed ID: 37820583
[TBL] [Abstract][Full Text] [Related]
20. Mathematical Modelling for the Role of CD4
Makhlouf AM; El-Shennawy L; Elkaranshawy HA
Comput Math Methods Med; 2020; 2020():7187602. PubMed ID: 32148558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
